You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. Physical Sub-Model Development for Turbulence Combustion Closure

    SBC: Corvid Technologies LLC            Topic: AF13AT12

    ABSTRACT: Corvid Technologies, in partnership with Clemson University"s combustion modeling group, is pleased to offer a physical sub-model evaluation and development plan for turbulent combustion applications relevant to the Air Force. We will leverage the computational resources and combustion modeling expertise from both parties to evaluate the current state of combustion modeling and then tra ...

    STTR Phase I 2014 Department of DefenseAir Force
  2. Command and Control, Modeling and Simulation, Training

    SBC: Sonalysts, Inc.            Topic: MDA13T005

    The Sonalysts Team proposes to investigate, design, and develop a training system leveraging state-of-the art game and agent-based technologies with"TRILOGY,"a Modeling, Simulation, and Training (MST) system capable of three core capabilities: training, rehearsal, and analysis/CONOPS development. Sonalysts will leverage their latest commercial-off-the-shelf (COTS) game engine, Simulation Engine I ...

    STTR Phase I 2014 Department of DefenseMissile Defense Agency
  3. Data-Parallel Analytics on Graphics Processing Units (GPUs)

    SBC: SYSTAP, LLC            Topic: ST13B004

    The proposed effort will extend existing proofs of concept and advanced research systems to: (a) provide an efficient, low-level, data-parallel runtime for graph processing on GPUs; (b) provide a high-level abstraction for writing graph analytics that are

    STTR Phase I 2014 Department of DefenseDefense Advanced Research Projects Agency
  4. Ultrafast Physical Random Number Generation Using Hybrid Boolean Networks

    SBC: Eno River Technologies Co.            Topic: A14AT002

    Eno River Technologies and Duke University propose to develop Hybrid Boolean Network (HBN) technology for ultrafast physical random number generation. HBNs are circuits composed partly of unclocked logic elements that exhibit chaotic dynamics and clocked elements that provide readout and synchronization to the system bus. It is hypothesized that the chaotic elements amplify electronic noise in t ...

    STTR Phase I 2014 Department of DefenseArmy
  5. Low Power Monolayer MoS2 Transistors for RF Applications

    SBC: KYMA TECHNOLOGIES, INC.            Topic: A14AT008

    Utilizing a novel solid/gas source CVD reactor designed for the growth of large area (substrates up to 4"in diameter) MoS2 single layer (SL) and multiple layer (ML) films, and leveraging already demonstrated capabilities in the growth and fabrication of 2D-FETs based on graphene and WSe2, we are proposing the growth, fabrication and testing of MoS2-based RF FETs. Utilizing a novel and optimized s ...

    STTR Phase I 2014 Department of DefenseArmy
  6. Secure Efficient Cross-domain Protocols

    SBC: Sonalysts, Inc.            Topic: AF13AT08

    ABSTRACT: The Sonalysts team proposes to develop a solution that facilitates the flow of data between different levels of classification while improving and ensuring both security and data integrity. Our approach involves a set of protocols that provide a unique and disruptive combination of multichannel data dispersion and multi-classification data management techniques to meet our objectives. ...

    STTR Phase I 2014 Department of DefenseAir Force
  7. New Class of Bright, Sharp, Tunable Near-Infrared Fluorophores for Flow Cyto

    SBC: Nirvana Sciences, Inc.            Topic: NIAID

    DESCRIPTION (provided by applicant): Polychromatic flow cytometry [FC] is one of the most powerful analytical techniques routinely used in immunology. Flow cytometry plays a critical role in several growing clinical applications: leukemia and lymphoma immunophenotyping for diagnosis and sub-categorization (now using 8-10 colors); in CD4/CD8 measurement in HIV-positive patients; and in HLA typing f ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  8. Non-ATP competitive inhibitors of cyclin dependent kinases as cancer therapeutics

    SBC: PPI PHARMACEUTICALS, LLC            Topic: NCI

    DESCRIPTION (provided by applicant): As cancer is one of the leading causes of death in the United States with some sub-types remaining essentially untreatable, expansion of available drug targets will provide significant new options for the development ofmore effective antineoplastic agents. The major goal of this project is to apply a unique drug discovery strategy to cancer drug development. Th ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  9. AAV2-ASPA-Based Metabolic Intervention for Alzheimer's Disease

    SBC: ASKLEPIOS BIOPHARMACEUTICAL, INC.            Topic: NIA

    Abstract We propose to initiate preclinical development of a gene therapeutic targeted to Alzheimer's Disease. The World Health Organization's and Alzheimer's Disease International's report on Dementia (2012) recognizes that the global burden of AlzheimerDisease is forecast to worsen significantly with prevalence predicted to double every 20 years. Interventions that could prov ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  10. Removal of Amyloid-beta Peptides from the Alzheimer's Brain

    SBC: WE BIOSCIENCES, LLC            Topic: NIA

    DESCRIPTION (provided by applicant): As the Alzheimer's disease (AD) population is growing rapidly, currently there are no cure treatments. The goal of this resubmitted STTR proposal is to conduct a preclinical study with pramlintide to prove a potential treatment for AD. We have revised the proposal significantly according to the reviewers' comments. Pramlintide is an FDA approved drug ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government